1Palosuo T, Lukka M, Alenius H, et al. Purification of filaggrin from human epidermis and measurement of antifilaggrin autoantibodies in sera from patients with rheumatoid arthritis by an enzyme-linked immunosorbent assay. Int Arch Allergy Appl Immunol, 1998,115 : 294-302.
2Wolfe F, Cathey MA, Roberts FK. The latex revisited rheumatoid factor testing in 8 287 rheumatic diseases patients. Arthritis Rheum, 1991,34:951.
3Sehellekens GA, de Jong BA, Van den Hoogen FILl, et al. Citruline is an essential constituent of antigenic determinants recognized by rheurrmtoid arthritis-specific autoantibodies. J Clin Invest, 1998,101:273-281.
4Despres N, Boire G, Lopez-Longo FJ, et al. The Sa system: a novel antigen-antibody system specific for rheumatoid arthritis. J Rheumatol, 1994,21 : 1027-1033.
5Menard HA, Lapointe E, Rochdi MA, et al. Insights into rheumatoid arthritis derived from the Sa immune system. Arthritis Res, 2000,2:429-432.
6Paimela L, Gripengerg M, Kurki P, et al. Antikeratin antibodies:diagnostic and prognostic markers for early rheumatoid arthritis.Ann Rheum Dis, 1992, 51: 743-746.
7Gerard A, Schellekens GA, Hendrik V, et al. The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclie citrullinated peptide. Arthritis Rheum, 2000, 43: 155-163.
8Anil V. Diagnosing early-onset rheumatoid arthritis: the role of anti-CCP antibodies. Am Clin Lab, 2002, 8: 34-36.
9Nicola B, Giovanni M, Elio T, et al. Diagnostic accuracy of the anti-citrulline antibody assay for rheumatoid arthritis. Clin Chem,2001, 47: 1089-1093.
10Furst DE. Predictors of worsening clinical variables and outcomes in rheumatoid arthritis. Rheum Dis Clin North Am, 1994, 20:309-319.
